Product Description: 4-Phenylbutyric acid (4-PBA) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, used in cancer and infection research.
Applications: Cancer-programmed cell death
Formula: C10H12O2
Citations: Acta Pharm Sin B. 2024 Apr 23./Acta Pharm Sin B. 5 January 2022./Adv Sci (Weinh). 2024 Sep 19:e2403442./Adv Sci (Weinh). 2025 Jan 21:e2403992./Anim Nutr. 5 October 2022./Animals (Basel). 2023 Jul 13, 13(14), 2291./Antioxid Redox Signal. 2023 Apr 13./Autophagy. 2021 Nov;17(11):3592-3606./Behav Brain Res. 2024 Jan 22:114871./Bioact Mater. 2023 Sep,257-270./Biochem Biophys Res Commun. 2024 Oct 28:737:150916./Biochem Pharmacol. 2022 Dec 30;115404./Biochem Pharmacol. 2022: 115343./Biochem Pharmacol. 2023 Jun 28;115666./Biochem Pharmacol. 2024 May:223:116194./Biochim Biophys Acta Mol Cell Biol Lipids. 2024 Aug 21:159559./Biomedicines. 2024 Apr 18;12(4):902./Biomolecules. 2024 Sep 8./bioRxiv. 2024 September 07./BMC Complement Med Ther. 2022 May 5;22(1):125./BMC Complement Med Ther. 2024 Nov 16;24(1):400./Br J Nutr. 2023 Sep 13;1-27./Br J Pharmacol. 2022 May 1./Bull Exp Biol Med. 2023 Apr 13;1-8./Cancer Lett. 2021 Apr 6;S0304-3835(21)00153-1./Cancer Lett. 2021 Nov 16;S0304-3835(21)00581-4./Cell Death Dis. 2020 Apr 24;11(4):279./Cell Death Dis. 2021 Jun 11;12(6):606./Cell Death Dis. 2022 Nov 10;13(11):951./Cell Death Dis. 2024 Dec 18;15(12):890./Cell Death Dis. 2024 Sep 30;15(9):702./Cell Death Discov. 2023 Aug 14;9(1):296./Cell Death Discov. 2024 Feb 20;10(1):91./Cell Death Discov. 2024 Jun 8;10(1):275./Cell Mol Biol Lett. 2023 Oct 12;28(1):79./Cell Signal. 2025 Mar 17:111753./Cell Stress Chaperones. 2022 Nov 28./Cells. 2022, 11(23), 3792./Chem Biol Drug Des. 2024 Jan 4./Chem Biol Interact. 2022 Aug 23;110125./Chem Biol Interact. 2023 Jun 1;110592./Chemosphere. 2022 Aug 7;307(Pt 2):135962./Chemosphere. 2023 Mar 24;327:138463./Commun Biol. 2024 Sep 5;7(1):1091./Dev Cell. 2024 Jul 3:S1534-5807(24)00385-X./Ecotoxicol Environ Saf. 2022 Sep 21;245:114099./Ecotoxicol Environ Saf. 2023 Mar 14;255:114725./Ecotoxicol Environ Saf. 2024 Aug 28:284:116946./Ecotoxicol Environ Saf. 2024 Jul 3:281:116639./Ecotoxicol Environ Saf. 2024 Oct 23:286:117243./Elife. 2020 Dec 7;9:e61405./Environ Int. 2023 Jan 13./Environ Int. 2023 Sep 27:180:108228./Environ Pollut. 2023 Dec 16:343:123167./Environ Toxicol. 2023 May 6./Exp Neurol. 2024 Feb 21:114738./Exp Ther Med. 2023 Sep 1./FASEB J. 2025 Mar 31;39(6):e70345./Fish Physiol Biochem. 2022 Jan 29./Fish Shellfish Immunol. 2024 Nov 9:155:110020./Food Chem Toxicol. 2020 Feb;136:111080./Food Chem Toxicol. 2022 Jun 28;113263./Food Chem Toxicol. 2023 Sep 20;114033./Foods. 2023 Apr 11, 12(8), 1616./Free Radic Biol Med. 2023 Jun 24./Free Radic Biol Med. 2025 Mar 13:S0891-5849(25)00168-6./Front Biosci (Landmark Ed). 2024 Sep 24;29(9):334./Front Cell Infect Microbiol. 14 June 2022./Front Oncol. 2021 Jul 7;11:663600./Front Pharmacol. 2022 Mar 21;13:854506./Int Immunopharmacol. 2021 Dec 22;103:107842./Int Immunopharmacol. 2021 Dec 27;103:108489./Int Immunopharmacol. 2025 Jan 4:147:113935./Int J Biol Macromol. 2024 Jun 4;272(Pt 2):132870./Int J Biol Macromol. 2024 Sep 11:135351./Int J Med Sci. 2024 Jan 1; 21(2):341-356./Int J Mol Med. 2025 May;55(5):77./Int J Mol Sci. 2023, 24(2), 1015./Int J Mol Sci. 2023, 24(3), 2749./Int J Nanomedicine. 2025 Jan 30:20:1147-1169./J Agric Food Chem. 2024 Feb 21;72(7):3741-3754./J Biochem Mol Toxicol. 2024 Nov;38(11):e70038./J Burn Care Res. 2023 Mar 4;irad029./J Dairy Sci. 2023 May 22;S0022-0302(23)00275-8./J Ethnopharmacol. 2022 Dec 15;116028./J Ethnopharmacol. 2023 Oct 5;319(Pt 2):117245./J Ethnopharmacol. 2024 Jan 12:117759./J Exp Clin Cancer Res. 2023 Jun 19;42(1):150./J Funct Foods. 2020, 104178./J Funct Foods. 2022, 99: 105336./J Funct Foods. 2024 Apr, 115, 106102./J Hazard Mater. 2023 Jan 12./J Lipid Res. 2024 Nov 4:100692./J Neuroimmune Pharmacol. 2024 Jan 12;19(1):1./J Orthop Surg Res. 2022 Nov 16;17(1):487./J Transl Med. 2024 May 21;22(1):488./Lab Invest. 2022 Aug 8./Life Sci. 2023 Apr 1;121656./Lipids Health Dis. 2025 Feb 11;24(1):44./Mar Drugs. 2024 Apr 13, 22(4), 174./MedComm-Oncology. 2023 Feb 19./Mol Biol Rep. 2023 Jun 16./Mol Carcinog. 2024 Jun 19./Mol Immunol. 2021 May 3;135:294-303./Mol Immunol. 2025 Mar 20:181:102-112./Mol Med Rep. 2024 May;29(5):71./Nat Cell Biol. 2024 Sep 11./Oncogene. 2024 Aug 28./Oxid Med Cell Longev. 2021 Jun 17./Oxid Med Cell Longev. 2022 Apr 6;2022:1835900./Oxid Med Cell Longev. 2022 May 5;2022:5695005./PeerJ. 2022 May 12;10:e13376./Pharmaceutical Science Advances. 2025 Dec./Phytother Res. 2022 Sep 9./Poult Sci. 2024 Jun;103(6):103656./Poult Sci. 2024 Mar 15, 103656./Research Square Preprint. 2022 Jun./Research Square Preprint. 2023 Jul 28./Research Square Print. 2022 Aug./Research Square Print. October 4th, 2022./Respir Res. 2023 Jun 2;24(1):149./Respir Res. 2024 Nov 9;25(1):401./Sci Immunol. 2023 Sep 29;8(87):eabq2424./Sci Rep. 2023 Jan 13;13(1):693./Sci Rep. 2023 Jan 20;13(1):1147./Sci Rep. 2023 Nov 9;13(1):19438./Sci Total Environ. 2023 Jun 1;164620./Sci Total Environ. 2024 Apr 20:172582./Sci Total Environ. 2024 Jan 17:915:170129./Sci Total Environ. 2025 Mar 17:973:179048./Small. 2022 Dec 4;e2204310./SSRN. 2024 Jul 11./Toxicol In Vitro. 2022: 105534./Toxicology. 2022 May 15;473:153193./Toxicology. 2024 Apr 9:504:153800./Toxicology. 2024 Dec:509:153979./Toxicology. 2024 Jul 18:153899./Toxicology. 2024 Oct 18:153976./Toxins. 2024 Oct 9;16(10):432./Vet Microbiol. 2021 Feb;253:108959./Vet Microbiol. 2023 Jan 24;279:109666./Vet Microbiol. 2024 May, 292, 110051./Vet Res. 2024 Jun 14;55(1):78./Virulence. 2025 Dec;16(1):2466482./Viruses. 2023, 15(2), 534./Am J Physiol Cell Physiol. 2025 Feb 21./Arterioscler Thromb Vasc Biol. 2022 Mar;42(3):305-325./Autophagy. 2022 Feb 7;1-18./Biosci Rep. 2019 Aug 7;39(8):BSR20190578./Cell Death Dis. 2018 Nov 16;9(12):1143. /Cell Stress Chaperones. 2022 May;27(3):273-283./Chem Biol Interact. 2023 May 3;110523./Ecotoxicol Environ Saf. 2022 May 1;236:113508./FEBS Open Bio. 2020 Oct;10(10):2122-2136./Food Chem Toxicol. 2020 Jun;140:111329./Front Oncol. 2021 Oct 27;11:722624./Front Pharmacol. 2021 May 24;12:685895./Int Immunopharmacol. 2021 Oct 25;101(Pt A):108281./Int J Clin Exp Med. 2019;12(5):5184-5190./J Invest Dermatol. 2024 Jul 1./J Mol Med (Berl). 2019 Aug;97(8):1183-1193./Lett Drug Des Discover. 2019 Nov./Nutr Metab. 2020 Jan 30;17:11./Res Sq. 2024 Aug 21./Toxicol Res. 2021 Jan 5./Vet Res. 2023 Mar 22;54(1):27.
References: [1]Chang TH, et al. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. Clin Cancer Res. 2002 Apr;8(4):1206-12./[2]Frouco G, et, al. Sodium phenylbutyrate abrogates African swine fever virus replication by disrupting the virus-induced hypoacetylation status of histone H3K9/K14. Virus Res. 2017 Oct 15;242:24-29./[3]Park HJ, et al. 4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts. Biochem Pharmacol. 2018 May;151:9-17.
CAS Number: 1821-12-1
Molecular Weight: 164.20
Compound Purity: 99.98
Research Area: Cancer; Infection
Solubility: DMSO : 100 mg/mL (ultrasonic)/H2O : 2 mg/mL (ultrasonic)
Target: HDAC;Virus Protease
English
Deutsch
